{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:46Z","timestamp":1787010226749,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>Sirolimus (mammalian target of rapamycin inhibitor) is a potent immunosuppressive agent, used in patients receiving hematopoietic stem cell transplant (HSCT) for Graft vs Host disease prophylaxis. Compared to calcineurin inhibitors, sirolimus has no neurotoxicity or nephrotoxicity, but sirolimus causes dose-dependent thrombocytopenia, leukopenia, delayed wound healing, hyperlipidemia, and hypertriglyceridemia. Here we report a case of acute pancreatitis and diabetic ketoacidosis in a patient with sickle cell disease post haploidentical family donor HSCT which was managed conservatively without plasmapheresis. Based on our review of the literature, this is the first reported case of developing acute pancreatitis as an adverse effect of sirolimus-induced hypertriglyceridemia leading to diabetic ketoacidosis in a recipient of HSCT.<\/jats:p>","DOI":"10.1097\/mph.0000000000002793","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T13:03:58Z","timestamp":1701263038000},"page":"e91-e93","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Sirolimus-induced Hypertriglyceridemia Leads to Acute Pancreatitis and Diabetic Ketoacidosis Post Stem Cell Transplant for Sickle Cell Disease"],"prefix":"10.1097","volume":"46","author":[{"given":"Subhasish","family":"Paul","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Centre for Bone Marrow Transplant & Cellular Therapy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Nirmal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centre for Bone Marrow Transplant & Cellular Therapy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Chadha","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centre for Bone Marrow Transplant & Cellular Therapy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centre for Bone Marrow Transplant & Cellular Therapy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IPS","family":"Kochar","sequence":"additional","affiliation":[{"name":"Departments of Paediatric Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namith","family":"Jerath","sequence":"additional","affiliation":[{"name":"Pediatrics, Indraprastha Apollo Hospital, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Vohra","sequence":"additional","affiliation":[{"name":"Pediatrics, Indraprastha Apollo Hospital, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kharya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centre for Bone Marrow Transplant & Cellular Therapy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"issue":"3 suppl","key":"R1-20250804","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant Proc"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.drudis.2015.05.006","article-title":"Sirolimus and everolimus in kidney transplantation","volume":"20","author":"Moes","year":"2015","journal-title":"Drug Discov Today"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0897190017692920","article-title":"Severe hypertriglyceridemia induced by sirolimus treated with medical management without plasmapheresis: a case report","volume":"31","author":"Kido","year":"2018","journal-title":"J Pharm Pract"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/00007890-200005270-00019","article-title":"Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management","volume":"69","author":"Hong","year":"2000","journal-title":"Transplantation"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41409-020-01054-3","article-title":"Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease","volume":"56","author":"Kharya","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood.2019001323","article-title":"How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide","volume":"134","author":"McCurdy","year":"2019","journal-title":"Blood"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/1744-9987.12371","article-title":"Possible sirolimus-induced acute pancreatitis in a renal transplant recipient","volume":"20","author":"Ratkovic","year":"2016","journal-title":"Ther Apher Dial"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/TP.0b013e3181caa5e4","article-title":"Sirolimus-induced severe hypertriglyceridemia in a lung transplant recipient","volume":"89","author":"Fernandez-Bussy","year":"2010","journal-title":"Transplantation"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/TP.0b013e318177281e","article-title":"Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients","volume":"86","author":"Celik","year":"2008","journal-title":"Transplantation"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1016\/S0041-1345(98)01301-3","article-title":"Hypertriglyceridemia in renal transplant recipients treated with sirolimus","volume":"30","author":"Brattstr\u00f6m","year":"1998","journal-title":"Transplant Proc"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"P666","DOI":"10.1016\/j.annemergmed.2017.01.002","article-title":"Diabetic ketoacidosis and acute pancreatitis: serious adverse effects of everolimus","volume":"69","author":"Acharya","year":"2017","journal-title":"Ann Emerg Med"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:03:35Z","timestamp":1754337815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002793","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"2023-07-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}